% | $
Quotes you view appear here for quick access.

Santarus, Inc. (SNTS) Message Board

  • chinesestockguru chinesestockguru Sep 3, 2013 3:50 PM Flag

    SiameseKitty711 -- I want to reason only one thing

    In the past I have posted Pharma companies which make $0 sales , and are in Phase II stage ( highly uncertain) they are valued $3 Billion and above

    Here we have a company which makes money and has Ruconest approval + Rifamycin MMX (both in 2014 ) and SAN 300 going into Phase II
    how come this is valued at $1.5 Billion ? besides that they have $2 / share cash + Par money which is going pour in..

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • When few years ago ONix making $ 250 mln had PPS of $19 and the MB was full of bashers.... I couldn't figure out what was that and .... sold. Now I know what was going on.

    • ACAD market cap $2 Billion , they don't make any bucks and company in huge loss for several years, all on hopes,, but i am surprised SAN 300 which is suppose to be a blockbuster hasn't got the momo ?

      Well, I think pretty soon , daytraders and boiler room jockeys will exit for speculative and enter into money making companies

      Sentiment: Strong Buy

    • Patience , any day company is going to release positive news as mentioned in the transcript

      Our SAN-300, our monoclonal antibody, which we plan to initially develop for both rheumatoid arthritis and inflammatory bowel disease, we have held a pre-IND meeting with the FDA to discuss a Phase IIa clinical study with a subcutaneous dosage formulation to evaluate safety, the efficacy parameters, and PK/PD and patients with rheumatoid arthritis, and are moving forward to submit an IND in the coming weeks.

      Could be up 20% on this news

      Sentiment: Strong Buy

    • I know what you mean. This is a gem and will go way higher. Cash is piling up and pipeline is fruitful. A phase 2 that I am now in is ZLCS. If the market cap is only 100-200 million it is OK to do them if they have a chance for good results. SNTS cash can be used to expand like QCOR and VPHM are doing. Not much to worry about here, buy the dips, some just saying this went up too fast (it made up for 1-2 bad years IMO).

31.960.00(0.00%)Dec 31 4:00 PMEST